Lansoprazole Tablet, Orally Disintegrating, Delayed Release
Product Images NDC 55154-4848

4 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 55154-4848). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 1)

Chemical Structure (Image 1)
Chemical structure of lansoprazole, an oral delayed-release orally disintegrating tablet. The diagram shows the molecular arrangement with key elements, including benzimidazole, sulfoxide, and trifluoromethyl groups, associated with lansoprazole's chemical identity.*
FDA Label Image

Figure-01 (Image 2)

Figure-01 (Image 2)
Line graph showing mean severity of day heartburn over time for evaluable patients in a study. The y-axis measures mean severity from 0 (none) to 3 (severe), while the x-axis shows days from start of treatment, ranging from -5 to 60. Three groups are compared: placebo, lansoprazole 15 mg once daily, and lansoprazole 30 mg once daily, with lansoprazole groups showing notably lower heartburn severity than placebo over time.*
FDA Label Image

Figure-02 (Image 3)

Figure-02 (Image 3)
A line graph showing the mean severity of night heartburn over days from the start of treatment in a study. The graph compares placebo, lansoprazole 15 mg once daily, and lansoprazole 30 mg once daily. The y-axis measures mean severity of night heartburn (0 to 3 scale), and the x-axis shows days from treatment start (up to 60 days). Lansoprazole groups show lower severity compared to placebo.*
FDA Label Image

30mg Bag Label (Eaa2693b B9df 4cf3 B212 5de87110aa89 00)

30mg Bag Label (Eaa2693b B9df 4cf3 B212 5de87110aa89 00)
Lansoprazole 30 mg delayed-release orally disintegrating tablets, package of 10 tablets. The label includes dosage form, strength, and manufacturer information, indicating it is distributed by Cardinal Health 107, LLC. The label notes the tablets contain 30 mg of lansoprazole as enteric-coated microgranules and includes storage instructions and warnings about package child resistance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.